- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07708454
Outcomes After First-line Treatment of Hand Osteoarthritis
Changes in Patient-reported Outcomes After a 3-month First-line Treatment Program in Men and Women With Hand Osteoarthritis
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
According to international guidelines, exercise, education and splinting (if needed) should constitute first-line treatment for people with hand osteoarthritis (OA). However, few studies have investigated the outcomes of such treatment in individuals with hand OA. In this retrospective register-based study the investigators will investigate the outcomes of 3-months participation of first-line treatment for hand OA using data from the Swedish Osteoarthritis register (SOAR). Outcomes will be self-reported change in pain, pain frequency, health-related quality of life, physical activity, fear of movement and willingness for joint surgery between baseline and three months follow-up. In addition, the investigators will investigate if potential improvements remain at 12 months.
Statistical analysis Changes in continuous variables between baseline and the two follow-ups (3 and 12 months) will be analyzed using paired T-test. Changes in proportions in the categorical variables will be analyzed using McNemars test for pairwise comparisons. Standardized effect sizes will be reported as Cohen's d with the following cut offs: 0.2=small, 0.5=medium and 0.8=large effect size. All outcomes will be analyzed separately for females and males.
In this study the investigators will include all participants registered in SOAR fulfilling the eligibility criteria outlined below (n>1000) and consequently no power calculation was performed.
Undersøgelsestype
Tilmelding (Faktiske)
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- a clinical diagnosis of hand OA
- participated for three months in the program
- reported any of the included outcomes at both baseline and at 3 months follow-up.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Hand osteoarthritis
Patients with a clinical diagnosis of hand osteoarthritis participating in a first-line treatment program
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
NRS pain
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
The NRS comprises an 11-point scale where 0 indicates no pain and 10 indicates the worst possible pain.
|
From enrollment to 3 and 12 months follow-up, respectively
|
|
Health-related quality of life
Tidsramme: From enrollment to 3 and 12 months, respectively
|
Assessed with the EuroQol - 5 dimension descriptive system (EQ-5D-3L)
|
From enrollment to 3 and 12 months, respectively
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain frequency
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
dichotomous, frequent/rare
|
From enrollment to 3 and 12 months follow-up, respectively
|
|
Physical activity
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
Assessed with the Swedish Board of Health and Welfare indicators
|
From enrollment to 3 and 12 months follow-up, respectively
|
|
Fear of movement
Tidsramme: from enrollment to 3 and 12 months follow-up, respectively
|
Dichotomous reply, yes/no
|
from enrollment to 3 and 12 months follow-up, respectively
|
|
Willingness for surgery
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
Dichotomous reply, yes/no
|
From enrollment to 3 and 12 months follow-up, respectively
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Anna Cronström, PhD, Lund University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Dnr: 2022-06657-01
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
IPD-delingsadgangskriterier
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .